MED-EL’s cochlear implants are now FDA-approved in children seven months and older with bilateral sensorineural hearing loss ...
FDA approves expanded indication for MED-EL cochlear implants for children seven months and older with bilateral sensorineural hearing loss.
Infants born deaf or hard of hearing show adverse changes in how their brains organize and specialize, but exposure to sound and language may help them develop more normally, according to ...
Sheffield, UK, July 1 2025 – Rinri Therapeutics, a world leading company focused on transforming sensorineural hearing loss (SNHL) with regenerative cell therapy, is pleased to announce the approval ...
One-third of congenital cytomegalovirus-related hearing loss would be missed without universal screening programs.